Expression of maspin in endometrioid adenocarcinoma of endometrium

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 393-398

  Li, Hang Wun Raymond ^a   Leung, See Wai ^a   Chan, Chun Sing Samuel ^a   Yu, May Mei Yung ^a   Wong, Yick Fu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endometrioid adenocarcinoma; Endometrium; Maspin

Indexed keywords

MASPIN; PRIMER DNA; SERINE PROTEINASE INHIBITOR;

ARTICLE; BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; CYTOPLASM; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

CARCINOMA, ENDOMETRIOID; CELL NUCLEUS; CYTOPLASM; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; UP-REGULATION;

EID: 33947725558     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.393     Document Type: Article

References (22)

1. Schaefer JS and Zhang M: Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 3: 653-658, 2003. (Pubitemid 37236407)
2. Sheng S: The promise and challenge toward the clinical application of maspin in cancer. Front Biosci 9: 2733-2745, 2004.
3. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994. (Pubitemid 24082753)
4. Domann FE and Futscher BW: Maspin as a molecular target for cancer therapy. J Urol 169: 1162-1164, 2003. (Pubitemid 36188193)
5. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817, 2001. (Pubitemid 32708715)
6. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJC: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932, 2002. (Pubitemid 35025740)
7. Li HWR, Leung SW, Cheung ANY, Yu MMY, Chan LKY and Wong YF: Expression of maspin in gestational trophoblastic disease. Gynecol Oncol 101: 76-81, 2006.
8. Umekita Y, Ohi Y, Sagara Y and Yoshida H: Expression of maspin predicts poor prognosis in breast cancer patients. Int J Cancer 100: 452-455, 2002.
9. Umekita Y and Yoshida H: Expression of maspin is upregulated during the progression of mammary ductal carcinoma. Histopathology 42: 541-545, 2003. (Pubitemid 36688147)
10. Mohsin SK, Zhang M, Clark GM and Craig AD: Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 199: 432-435, 2003. (Pubitemid 36411219)
11. Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, Luttges J, Morohoshi T, Kloppel G and Nagasaki K: Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 199: 193-200, 2003. (Pubitemid 37297712)
12. Son HJ, Sohn TS, Song SY, Lee JH and Rhee JC: Maspin expression in human gastric adenocarcinoma. Pathol Int 52: 508-513, 2002. (Pubitemid 35279079)
13. Bettstetter M, Woenckhaus M, Wild PJ, Rummele P, Blaszyk H, Hartmann A, Hofstadter F and Dietmaier W: Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 205: 606-614, 2005. (Pubitemid 40514834)
14. Ogasawara S, Maesawa C, Yamamoto M, Akiyama Y, Wada K, Fujisawa K, Higuchi T, Tomisawa Y, Sato N, Endo S, Saito K and Masuda T: Disruption of cell-type specific methylation at the maspin gene promotor is frequently involved in undifferentiated thyroid cancers. Oncogene 23: 1117-1124, 2004. (Pubitemid 38269965)
15. Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukusima M, Yamagishi S, Kawashima T, Okada D, Shimizu K and Kawamoto M: Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 79: 248-253, 2005. (Pubitemid 40037479)
16. Lonardo F, Li X, Siddiq F, Singh R, Al-Abbadi M, Pass HI and Sheng S: Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 51: 31-39, 2006. (Pubitemid 43088622)
17. Marioni G, Blandamura S, Giacomelli L, Calgaro N, Segato P, Leo G, Fischetto D, Staffieri A and de Filippis C: Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Histopathology 46: 576-582, 2005. (Pubitemid 40632315)
18. Gima T, Kato H, Honda T, Imamura T, Sasazuki T and Wake N: DCC gene alteration in human endometrial carcinomas. Int J Cancer 57: 480-485, 1994. (Pubitemid 24173090)
19. Foca C, Moses EK, Quinn MA and Rice GE: Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas. Gynecol Oncol 79: 244-250, 2000.
20. Zhang W and Zhang W: Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. Int J Oncol 20: 1145-1150, 2002.
21. Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444: 213-223, 2004.
22. Schmittgen TD and Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. Biochem Biophys Methods 46: 69-81, 2000.